Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care

Register

Login to your account using your email address in order to register.
If this is your first course with UCSF CME, please create a new account.

Brochure

Syllabus


Overview Objectives Accreditation Course Outline
Chairs Faculty Travel & Lodging Cancellation Policy


Department: Epidemiology and Biostatistics
Course Number: MEP15001
Activity Date(s): July 24- 25, 2014
Location: Hotel Kabuki
San Francisco, CA
Fees:

$425 Physicians (practicing and retired)
$325 Allied Health Professionals
$325 Fellows/Residents

 

Overview:

Presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 2-day course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging, such as CT and MRI scanning. The course will also critically review current treatment options and preview new treatments under study. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.

TARGET AUDIENCE
The course is designed for physicians and other professionals in health research or clinical care who would find additional scientific background in the disease helpful, including those specifically involved in osteoporosis such as clinical trial managers, statisticians, physical therapists, and radiologic technologists. No prior clinical or scientific training in osteoporosis is required.

Back To Top


Objectives:

An attendee completing this course should be able to improve clinical competence to:

  • Use the combination of both bone mineral density and the WHO/FRAX calculator to diagnose osteoporosis and predict fracture risk;
  • Include both non-pharmacological and pharmacological counseling and therapy to patients for osteoporosis prevention and management;
  • Include new pharmacological therapies in treatment of osteoporosis;
  • Evaluate the benefits and risks of continuing long-term osteoporosis therapy;
  • Recognize and treat osteoporosis.

Back To Top


Accreditation:

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit/sTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Pharmacy: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit™.

AAFP: This Live activity, 11th Annual Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care, with a beginning date of 07/24/2014, has been reviewed and is acceptable for up to 12.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Geriatric: The approved credits shown above include 12.25 credits toward meeting the requirement under California Assembly Bill 1820, Geriatric Medicine.

Back To Top


Course Outline:

 

Course Slides

 

THURSDAY, JULY 24, 2014

8:00AM Registration and Continental Breakfast

MORNING MODERATOR: DENNIS BLACK,PhD

Bone Strength and Fracture Epidemiology

8:30 Bone Structure and Function and the Bone
Remodeling Cycle
Dolores Shoback, MD

Q&A

9:20 Beyond BMD: Bone Quality and Bone Strength
Mary Bouxsein, PhD

Q&A

10:05 Break

10:25 Risk Factors for Fracture
Dennis Black, PhD

Q&A

Tools of Risk Assessment and Diagnosis

10:55 Osteoporosis Diagnosis: BMD, FRAX and
Assessment of Secondary Osteoporosis
Steven Harris, MD, FACP

Q&A

Special Topics in Osteoporosis

11:40 Lunch (on your own)

AFTERNOON MODERATOR: MARY L. BOUXSEIN, PHD

1:10 Bad to the Bones: Corticosteroids and

Prevention of Corticosteroid-induced Osteoporosis
Nancy Lane, MD

Q&A

1:45 Bad to the Bones: Cancer Treatments and
Other Medications
Jonathan Graf, MD

Q&A

2:20 Ask for a Consult. Panel on treatment of
osteoporosis secondary to medications.
Jonathan Graf, MD
Steven Harris, MD
Nancy Lane, MD

2:50 Break

3:10 Kyphosis: Causes, Consequences, Treatment
Wendy Katzman, PhD

Q&A

3:50 Osteoporosis in Chronic Kidney Disease
Nancy Lane, MD

Q&A

Treatment and Prevention: Non- Pharmacologic Interventions

4:25 The Other Half of the Fracture Equation:
Fall Prevention and Management
Edgar Pierluissi, MD

Q&A

5:00 Adjourn


FRIDAY, JULY 25, 2014

8:00 AM Continental Breakfast

MORNING MODERATOR: DEBORAH E. SELLMEYER, MD

8:30 Controversies in the Use of Vitamin D and
Calcium
Deborah Sellmeyer, MD

Q&A

9:10 Case Studies of Interpretation of BMD Scans
Deborah Sellmeyer, MD

Q&A

9:50 Break
Treatment and Prevention: Pharmacologic
Interventions

10:10 Bisphosphonates: Efficacy Dennis Black, PhD

Q&A

10:40 SERMS and estrogen
Clifford Rosen MD

Q&A

11:00 Teriparatide Alone and in Combination
with Anti-Resorptives
Anne Schafer, MD

Q&A

11:25 Denosumab Clifford Rosen, MD

Q&A

11:45 Lunch (on your own)

AFTERNOON MODERATOR: ANNE SCHAFER, MD

Treatment and Prevention: Pharmacologic
Interventions continued

1:15 Controversies in Long Term Treatment
Dennis Black, PhD

Q&A

1:45 Odanacatib and Anti-sclerostin Antibody:
New Treatments on the Horizon
Mary Bouxsein, PhD

Q&A

2:10 Bone Turnover Markers to Monitor
Treatment
Doug Bauer, MD

Q&A

2:35 Break

2:55 Vertobroplasty and Kyphoplasty Doug Bauer, MD

Q&A

Clinical Issues, Choices, and Dilemmas in
Osteoporosis Therapy

3:25 An Overview of Treatment: Who and When to Treat
Dolores Shoback, MD

Q&A

4:00 Ask for a Consult. A Roundtable on Osteoporosis Cases.
Steven Harris MD
Deborah Sellmeyer MD
Cliff Rosen MD

4:40 Adjourn/Evaluations/Certificates

Back To Top


Chairs:

Dennis M. Black, PhD
Professor of Epidemiology
and Biostatistics
University of California, San Francisco

Ann V. Schwartz, PhD
Associate Professor of
Epidemiology and Biostatistics
University of California, San Francisco

Back To Top


Faculty:

Mary L. Bouxsein, PhD
Associate Professor,
Department of Orthopedic Surgery
Harvard Medical School,
Boston, MA

Nancy Lane, MD
Endowed Professor of Medicine
and Rheumatology
University of California at Davis
Davis, CA

Clifford J. Rosen, MD
Professor of Medicine
Tufts University School of Medicine
Maine Medical Center Research
Institute
Scarborough, ME

Deborah E. Sellmeyer, MD
Associate Professor of Medicine,
Director, Johns Hopkins
Metabolic Bone Center
Baltimore, MD

UCSF COURSE FACULTY
(University of California, San Francisco)

Douglas C. Bauer, MD
Professor of Medicine and of
Epidemiology and Biostatistics

Jonathan Graf, MD
Associate Professor of Medicine;
Division of Rheumatology,
San Francisco General Hospital

Steven T. Harris, MD, FACP
Professor of Medicine

Wendy Katzman, PT, DPTSc
Assistant Professor of Physical
Therapy & Rehabilitation Science

Edgar Pierluissi, MD
Associate Professor of Medicine
Medical Director of the Acute Care
for Elders Unit at the San Francisco
General Hospital

Anne Schafer, MD
Assistant Professor of Medicine,
Division of Endocrinology
San Francisco VA Medical Center

Dolores M. Shoback, MD
Professor of Medicine, UCSF
Endocrine Research Unit
San Francisco VA Medical Center

Back To Top


Travel & Lodging:

Hotel Kabuki
1625 Post Street
San Francisco, CA 94115
Hotel Direct: 415-433-6600
Toll free Reservations: 800-533-4567
Hotel Rates: $209
Cut Off Date: 6/23/14

To reserve online, please visit this link

Back To Top


Cancellation Policy:

Cancellations received in writing before the first day of the course will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.

Back To Top